This document is a research article from the ALSUntangled Group reviewing the evidence for using fecal microbiota transplantation (FMT) to treat ALS. It discusses the rationale behind FMT, its effectiveness in treating other conditions, and the potential role of the gut microbiome in neurodegenerative diseases. The article concludes that there is no direct evidence supporting FMT for ALS treatment but suggests further research into the gut microbiome's role in ALS.
documents/EFTA01178505.pdf
{}